Identification and Characterization of Cells with Cancer Stem Cell Properties in Human Primary Lung Cancer Cell Lines

Ping Wang, Quanli Gao, Zhenhe Suo, Else Munthe, Steinar Solberg, Liwei Ma, Mengyu Wang, N. A. C. Westerdaal, Gunnar Kvalheim, Gustav GaudernackPLoS 2013 · DOI · OpenAlex

Abstract

Lung cancer (LC) with its different subtypes is generally known as a therapy resistant cancer with the highest morbidity rate worldwide. Therapy resistance of a tumor is thought to be related to cancer stem cells (CSCs) within the tumors. There have been indications that the lung cancer is propagated and maintained by a small population of CSCs. To study this question we established a panel of 15 primary lung cancer cell lines (PLCCLs) from 20 fresh primary tumors using a robust serum-free culture system. We subsequently focused on identification of lung CSCs by studying these cell lines derived from 4 representative lung cancer subtypes such as small cell lung cancer (SCLC), large cell carcinoma (LCC), squamous cell carcinoma (SCC) and adenocarcinoma (AC). We identified a small population of cells strongly positive for CD44 (CD44(high)) and a main population which was either weakly positive or negative for CD44 (CD44(low/-)). Co-expression of CD90 further narrowed down the putative stem cell population in PLCCLs from SCLC and LCC as spheroid-forming cells were mainly found within the CD44(high)CD90(+) sub-population. Moreover, these CD44(high)CD90(+) cells revealed mesenchymal morphology, increased expression of mesenchymal markers N-Cadherin and Vimentin, increased mRNA levels of the embryonic stem cell related genes Nanog and Oct4 and increased resistance to irradiation compared to other sub-populations studied, suggesting the CD44(high)CD90(+) population a good candidate for the lung CSCs. Both CD44(high)CD90(+) and CD44(high)CD90(-) cells in the PLCCL derived from SCC formed spheroids, whereas the CD44(low/-) cells were lacking this potential. These results indicate that CD44(high)CD90(+) sub-population may represent CSCs in SCLC and LCC, whereas in SCC lung cancer subtype, CSC potentials were found within the CD44(high) sub-population.

Introduction

Lung cancer remains the leading cause of cancer-related mortality globally. Despite advancements in treatment, high rates of recurrence and therapy resistance persist. The "Cancer Stem Cell" (CSC) hypothesis posits that a small sub-population of cells within a tumor possesses self-renewal and multi-lineage differentiation potential, acting as the primary drivers of tumor growth and recurrence. Identifying reliable markers for these cells is complicated by the high heterogeneity of lung cancer, which includes subtypes such as Small Cell Lung Cancer (SCLC), Adenocarcinoma (AC), Squamous Cell Carcinoma (SCC), and Large Cell Carcinoma (LCC). This study aimed to identify subtype-specific CSC markers using primary patient-derived samples established in a robust culture system.

Methods

Researchers established 15 Primary Lung Cancer Cell Lines (PLCCLs) from 20 fresh primary tumors using a specialized serum-free culture system (DK-SFM) to prevent fibroblast contamination. The lines were authenticated using STR profiling. Cells were sorted using Fluorescence-Activated Cell Sorting (FACS) based on the expression of CD44 and CD90. The "stemness" of these sorted populations was evaluated through functional assays, including 2D colony formation (holoclones), 3D spheroid formation in low-attachment conditions, and in vivo tumorigenicity in NOD/SCID mice. Molecular characterization involved qPCR for embryonic stem cell genes (Nanog, Oct4, Sox2) and Epithelial-Mesenchymal Transition (EMT) markers (N-Cadherin, Vimentin). Radiation resistance was assessed by exposing cells to 1–4 Gy of X-ray radiation.

Results

The study successfully established a panel of primary lines representing the major lung cancer subtypes, providing a more accurate model than traditional commercial lines.

Morphology of Primary Large Cell Carcinoma (LCC) line LC006.

In SCLC and LCC subtypes, the combination of CD44$^{high}$CD90$^+$ identified the CSC population. These cells exhibited a spindle-like mesenchymal morphology and significantly higher spheroid-forming efficiency compared to CD44$^{low/-}$ populations. Furthermore, these cells showed elevated mRNA levels of Nanog and Oct4 and demonstrated superior survival following irradiation, linking these markers directly to therapy resistance.

Morphology of Primary Squamous Cell Carcinoma (SCC) line LC021.

In Squamous Cell Carcinoma (SCC), the CD44$^{high}$ marker alone was sufficient to identify cells with spheroid-forming potential, regardless of CD90 expression. Conversely, markers for Adenocarcinoma (AC) remained less definitive, as no single marker combination consistently identified a CSC population in this subtype, highlighting the complexity of this specific histology.

Discussion

This research underscores that CSC markers are subtype-specific in lung cancer. The association between CD44$^{high}$CD90$^+$ expression and EMT markers suggests that the transition to a mesenchymal state is a key feature of lung CSCs in SCLC and LCC. The observed plasticity in marker expression highlights the dynamic nature of "stemness," suggesting that therapeutic strategies must account for the ability of cells to transition between stem and non-stem states. These primary cell lines provide a valuable platform for future drug screening aimed at eradicating the CSC populations responsible for treatment failure and tumor recurrence.

Summary updated

Abstract

Lung cancer (LC) with its different subtypes is generally known as a therapy resistant cancer with the highest morbidity rate worldwide. Therapy resistance of a tumor is thought to be related to cancer stem cells (CSCs) within the tumors. There have been indications that the lung cancer is propagated and maintained by a small population of CSCs. To study this question we established a panel of 15 primary lung cancer cell lines (PLCCLs) from 20 fresh primary tumors using a robust serum-free culture system. We subsequently focused on identification of lung CSCs by studying these cell lines derived from 4 representative lung cancer subtypes such as small cell lung cancer (SCLC), large cell carcinoma (LCC), squamous cell carcinoma (SCC) and adenocarcinoma (AC). We identified a small population of cells strongly positive for CD44 (CD44(high)) and a main population which was either weakly positive or negative for CD44 (CD44(low/-)). Co-expression of CD90 further narrowed down the putative stem cell population in PLCCLs from SCLC and LCC as spheroid-forming cells were mainly found within the CD44(high)CD90(+) sub-population. Moreover, these CD44(high)CD90(+) cells revealed mesenchymal morphology, increased expression of mesenchymal markers N-Cadherin and Vimentin, increased mRNA levels of the embryonic stem cell related genes Nanog and Oct4 and increased resistance to irradiation compared to other sub-populations studied, suggesting the CD44(high)CD90(+) population a good candidate for the lung CSCs. Both CD44(high)CD90(+) and CD44(high)CD90(-) cells in the PLCCL derived from SCC formed spheroids, whereas the CD44(low/-) cells were lacking this potential. These results indicate that CD44(high)CD90(+) sub-population may represent CSCs in SCLC and LCC, whereas in SCC lung cancer subtype, CSC potentials were found within the CD44(high) sub-population.
BibTeX
@inproceedings{wang2013identification,
  author = {Ping Wang and Quanli Gao and Zhenhe Suo and Else Munthe and Steinar Solberg and Liwei Ma and Mengyu Wang and N. A. C. Westerdaal and Gunnar Kvalheim and Gustav Gaudernack},
  title = {{Identification and Characterization of Cells with Cancer Stem Cell Properties in Human Primary Lung Cancer Cell Lines}},
  booktitle = {PLoS},
  year = {2013},
  doi = {10.1371/journal.pone.0057020},
}

Loading related content...

Figure